unknown
Stage
1
Investors
About
European company operating in the Nutrition & Preventive Medicine sector in which Mérieux Equity Partners holds a minority buyout stake (entry date 2022).
Explore Biobest's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.